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EXECUTIVE SUMMARY 
There is a need to extrapolate from in vitro concentrations to in vivo dose. To do this extrapolation it is 
necessary to be able to calculate free concentrations in both systems and then compare them. 
Concerning the in vitro side, in the first part of this work, we had developed and implemented, based 
on HTS (High Throughput Screening) laboratory data, a compound fate model using the partitioning 
approach. The developed fate model was able to predict the role of serum in toxicity assays as well as 
provide estimation on the partitioning of a certain compound between the headspace, plastic wall and 
the medium: attached to serum, free dissolved and attached to the cells. However, the partitioning 
approach assumes that the equilibrium is fast in comparison with the duration of the experiments, 
which could not be the case for the partitioning to the cells. For this reason, a DEB (Dynamic Energy 
Budget) stage-based toxicity model has been developed and experimentally verified in the second part 
of this work. In addition, the model allows using internal concentrations as another toxicity scale 
allowing a toxicodynamics’ independent raking of the toxic potency of a chemical and the possibility 
of toxicity data reconciliation from several sources taking into account the inherent dynamics always 
present during cell-based assays. The results show that this approach opens a new way of analyzing 
this type of data sets and offers the possibility of extrapolating the values obtained to calculate in vivo 
human toxicology thresholds using a PBTK modelling approach. 
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1. INTRODUCTION 
The need for animal replacement in toxicology testing calls for the development of an Integrated 
Testing Strategy (ITS) able to move from in vitro toxic concentrations to in vivo dose without the 
passage to animal testing and the application of the corresponding assessment factors. This implies the 
need to consider toxicodynamics as an important, if not essential, part in the risk assessment strategy 
(Pelkonen et al., 2011). The characterization of the concentration that produces the toxic effect it is 
necessary at two levels; first for the in vitro experiments since “nominal” concentrations does not 
represent the real concentration experienced by the cell and second in the extrapolation of the dose for 
human toxicity assessment since to assess the hazard of a chemical compound we need to know the 
real concentration experienced by the target organ. One possible way to solve both problems, and be 
able to compare the same concentrations from in vitro and in vivo experiments, is the use of 
biology/physiology-based toxicodynamic models at both levels. For in vitro experiments a model 
comprising the fate of a compound in the cell-based assay, i.e. its partitioning between plastic wall, 
serum proteins and lipids, as well as the dynamics within the cell combined with a toxic effect model 
and, if necessary, a cell growth model, constitute the basis for the calculation of the realistic conditions 
when direct concentration measurements are not possible. For the establishment of a safe in vivo 
human dose intake reverse dosimetry, based on a battery of in vitro test, using Physiological Based 
Toxicokinetics models -PBTK or PBPK-(Clewell et al. 2008) seems the most promising route to 
explore. 
The first attempts to assess the applicability of this strategy for the safety evaluation of chemicals were 
based on the following elements (DeJongh et al., 1999; Gubbels-van Hal et al., 2005): 
- in vitro/ QSAR data on ADME (Absorption, Distribution, Metabolism, Excretion) as input data to 
- PBPK modelling (rat, human, etc.) for calculating target tissue concentration in vivo for the 
prediction of dose-response curves, NOEL (Not Observed Effect Level), LOEL (Lowest Observed 
Effect Level), etc. 
- in vitro and in vivo studies to validate the approach. 
The application of this approach to a reduced set of substances (10) to REACH requirements at 
production levels > 10 tonnes shown that it was possible to reduce by 38% the number of animals 
used, but further improvement was foreseen with the refinement of the procedure (Gubbels-van Hal et 
al., 2005).  
Concerning in vitro tests the suggested refinements (Gubbels-van Hal et al., 2005) in the ITS included 
the need to estimate the partitioning and bioavailability of the chemical in the assay to improve the 
methodology used to relate in vitro toxic concentrations to in vivo target tissue concentrations. 
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In a more recent attempt, Rotroff et al. (2010) estimated the human oral equivalent dose necessary to 
produce equivalent concentration levels using a human PBTK model and in vitro toxicity AC50 values 
from ToxCast datasets (http://www.epa.gov/ncct/toxcast/chemicals.html) together with metabolic 
clearance and plasma protein binding experimental data. They found that two compounds over the 35 
chemicals shown oral equivalent doses and estimated exposures which indicated the need to focus 
regulatory attention on these chemicals. 
In the first part of this work (Zaldívar et al., 2010), we had developed and implemented, based on HTS 
(High Throughput Screening) laboratory data, a compound fate model using the partitioning approach. 
The developed fate model was able to predict the role of serum in toxicity assays as well as provide 
estimation on the partitioning of a certain compound between the headspace, plastic wall and the 
medium: attached to serum, free dissolved and attached to the cells. However, the partitioning 
approach assumes that the equilibrium is fast in comparison with the duration of the experiments 
which could not be the case for the partitioning to the cells. For this reason, a DEB (Dynamic Energy 
Budget) stage-based toxicity model (Kooijman, 2000) has been developed and experimentally verified 
in the second part of this work.  
In addition, an aspect as important as the partitioning of the chemical in the cell assay is the dynamics 
of the cells during the experiment. The fundamental process is the growth of the cell population which 
will change the partitioning during the experiment and therefore the toxic effects experienced by the 
cells. In principle growth may be seen as a dilution process, but also affects the dynamics of the 
compound exchange between the cells as the medium. Furthermore, some cells are able to release 
proteins and lipids to the medium, e.g. albumin by HEPG2 cells that may also change the partitioning. 
The results of the model has been used to analyze the Neutral Red Uptake (NRU) cytotoxicity assay 
using the BALB/c 3T3 cells for several compounds This approach opens a new way of analyzing this 
type of data sets and it offers the possibility of extrapolating the values obtained to calculate in vivo 
human toxicology thresholds using reverse dosimetry in a PBTK modelling set-up. 
2. METHODS AND APPROACH 
Normally dose-response curves in in vitro experiments are represented using the total amount of 
substance added and not the dissolved (free) concentration which is the bioavailable fraction able to 
produce a toxic effect. Therefore, in vitro dose response curves (or their potency data e.g. EC50, IC50 
values) does not properly reflect the real toxic potency of a chemical since the compound will partition 
into the medium dissolved organic and particulate organic carbon (mainly serum and cells), and into 
the plastic walls as well as into the headspace (Gülden at al., 2001; Heringa et al., 2004; Kramer, 2010, 
amongst others). Another aspect that should be considered when volatile compounds are tested is the 
possibility of evaporation and cross contamination.  
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In addition, during the experiments cells growth and divide consuming nutrients, therefore the 
partitioning characteristic of the medium changes with time as well as the internal concentrations in 
the cells, complicating even further the comparison between different in vitro experiments and systems 
and therefore call for an integrated modelling approach able to quantify all this aspects and to “correct” 
the nominal concentrations as a function of the cell assay and the physico-chemical properties of the 
tested compounds. Therefore this integrated modelling approach must consist of: 
- A fate and transport model 
- A cell growth and division model 
-  A toxicodynamics model 
The solution of the ordinary differential equations of the model should allow the calculation over time 
of the dissolved concentration of a chemical as well as the internal concentration in the cell assay. We 
are briefly going to illustrate the different models and how they are interrelated. 
In this second work, we will develop and test the growth and toxicodynamics models coupled with the 
fate and transport model previously developed in Zaldívar et al. (2010). 
2.1. CELL ASSAYS GROWTH AND DIVISION MODEL 
The use of continuous ordinary differential equations ignores population structure by treating all 
individuals as identical. The existence of demographically important differences among individuals is 
obvious. Matrix population models (Caswell, 1989) integrate population dynamics and population 
structure and they are very useful when the life cycle is described in terms of size classes or age 
classes. There are fundamentally two types of approaches, the age classified model and the stage 
classified model. The first one assumes age-specific survival and fertility are sufficient to determine 
population dynamics. On the other hand, if the vital rates depend on body size, and growth is 
sufficiently plastic that individuals of the same age may differ appreciably in size, then age will 
provide little information about the fate of an individual (e.g. fish models, see Zaldívar and 
Campolongo, 2000). For the case of the 3T3 cell model, we have considered that the appropriate 
description corresponds to a four stage-based approach, each stage corresponding to one of the four 
cell cycle phases: G1, S, G2, M (Hartell and Weinert, 1989). 
In the stage-based type of modelling the matrix A, called Leslie matrix, which describes the 
transformation of a population from time t to time t+1, 
nt+1= A nt (1) 
has the following structure: 
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where nt is a vector describing the population at each stage at time t, Pi is the probability of surviving 
and staying in stage i; Gi is the probability of surviving and growing into the next stage, and F is the 
fecundity rate per unit time (h), i = 1,2,...,q.  
Both Pi and Gi are functions of the survival probability pi and the growth probability γi (Caswell 1989): 
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where zi is the hourly instantaneous mortality rate and di is the duration (h) within the i-th stage. 
Incorporation of interaction between species at different stages can be easily done (Cushing, 1998; 
Zaldívar and Campolongo, 2000).  
2.2. BIOCONCENTRATION AND BIOACCUMULATION IN CELLS 
Simple mass balance models of a contaminant in an organism (Thomann, 1989 and Thomann et al., 
1992) consider the organisms as a single compartment. A more complete model was developed, based 
on the Dynamic Energy Budget (DEB) approach, by Kooijman and van Haren (1990) and van Haren et 
al. (1994) that takes into account changes in lipid contents and size of the organisms. With this 
approach toxic effects introduced at population level can be extended to ecosystem level. The 
introduction of DEB models into matrix population models has been developed recently (Lopes et al., 
2005; Klanjscek et al., 2006; Billoir et al., 2007). Following this approach, we have considered that 
once the chemical is taken up by the cell it partition instantaneously over three compartments: one 
aqueous fraction and two non-aqueous fractions: structural component (proteins) and the energy 
reserves (lipids). This approach is represented in Figure 1 following Kooijman and van Haren (1990). 
In this case, the total number of moles of a compound in the organism can be divided as the sum of 
them in the different compartments: 
)( LLPPaqaqLPaqtot CVCVCVnnnn ⋅+⋅+⋅=++=  (7) 
where the Vi’s refer to the compartment volumes (l) and the Ci’s refer to the compartments 
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concentrations (mol l-1). Also, the total number of moles of a chemical can be expressed as: 
MWCWn btot /⋅=  (8) 
where W is the organisms weight (g), MW is the molecular weight of the chemical (g mol-1) and Cb is 
the contaminant concentration in the cell (g.gww-1) . 
The chemical is assumed to be in equilibrium between the different compartments with fixed values 
partition coefficients: KP=Cp/Caq and KL=CL/Caq. 
 
Figure 1. Schematic representation of the chemical partitioning in the cellular compartments. 
 
The time evolution of this substance in the cell can be calculated by a simple mass balance, assuming 
that uptake and depuration rates, rda and rad (l cm-2 s-1), are proportional to the surface area of the cell 
(passive diffusion), and the transfer occurs through the aqueous compartment only (Kooijman, 2000), 
as: 
)(3/2 aqaddissdatot CrCrVdt
dn
⋅−⋅=
 (9) 
where Cdiss and Caq refer to the dissolved fraction concentration in the medium (mol l-1) and in the 
aqueous compartment of the cell (mol l-1), respectively. However, it is more convenient to express the 
mass balance as a function of the cell’s concentration, Cb (g gww-1). Therefore, applying the chain rule 
of derivation to Eq. (8), we have: 

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and rearranging terms we obtain: 
dt
dW
W
CCrCr
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dC b
aqaddissda
b
−⋅−⋅
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= )(
3/2
 (11) 
In this case, the last term represents the dilution due to growth of the cell. This is a more realistic 
assumption that the linear-constant function assumed in the first bioaccumulation models (Thomman, 
1989).  
Since the concentration in the aqueous fraction, Caq, is not a value that is measured, then we have to 
convert it in terms of Cb using the partitioning approach. The wet weight, W, can also be expressed as a 
function of the volumes of the different compartments times the density (ρ in g l-1): 
( )aq P LW V V V Vρ ρ= ⋅ = + +  (12) 
For 3T3 ρ = 1195 g l-1 (Meisler, 1973). In addition, assuming that the mass proportion between 
proteins, lipids and aqueous fraction does not change appreciably in the cells during growth, the 
following relationships can be written: 
PPP WV ρ/=  (13) 
LLL WV ρ/=  (14) 
aqaqaq WV ρ/=  (15) 
where WP , WL and Waq are the masses of proteins, lipids and aqueous compartments in the cells and 
ρP, ρL and ρaq their densities, i.e, 1350, 900 and 1000 g.l-1, respectively. 
To find the correlation between Caq and Cb, we have to combine ntot in Eqs. (7)-(8), the partition 
coefficients, and Eqs, (13)-(15), then we have: 
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where the fi refer to the mass fractions of each compartment (aqueous, lipid, proteins) in the cell. For 
3T3 we have: faq=0.244, fL=0.142; fP= 0.614 (Meisler, 1973).  
Replacing this equation into Eq. (11) and rearranging, we obtain a similar equation to the one proposed 
by Thomann (1989) and Thomann et al. (1992): 
2/3 2/3 1b
da diss ad b b
aq L P
L P
aq L P
dC MW V V dW
r C r C C
dt W W dtf f fW K Kρ ρ ρ
 
 
 ⋅    
= − −          + +   
  
  (17) 
However in this case uptake and depuration rates are not constant, but depend on the status of the cell 
and take into account the differences in growth. 
The variation of the wet weight, W, as a function of time can be obtained, assuming constant 
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composition and hence density, as:  
dW dV
dt dt
ρ=  (18) 
If we consider spherical shape, 34
3
V rpi= , and von Bertalanffy’s growth curve  
tGerrrtr ⋅−
∞∞
−−=
α)()( 0  (19) 
where r0 and r∞ refer to the initial and final cell radius and αG is the von Bertalanffy’s growth rate. 
Then we have: 
[ ]20 04 ( ) exp( ) ( ) exp( )G G GdV r r r t r r tdt pi α α α∞ ∞ ∞= ⋅ − − − ⋅ − ⋅ ⋅ − ⋅  (20) 
For 3T3: r∞=8.3057.10-6 m , r0=6.592.10-6 m, and αG=1.268.10-4. 
However, the introduction of this term considers only a single cell developing during the simulation. 
To consider the whole population of the cells, instead of a single cell, we will take average values for 
the weight, its derivative, and the surface depending on the four stages: G1, S, G2, M. 
The model in Eq. (17) has several parameters that need to be evaluated. The uptake and depuration 
rates, rda and rad, and the partition coefficients, KL and KP, depend on the compound; whereas the 
remain parameters depend on the type of cell we are modelling. 
2.3. TOXICITY AND EFFECTS MODELS 
The direct effects of a chemical concentration, C, on survival may be expressed, using Eq. (5), by the 
addition of a term which can be written as: 
0( )     if   and   i t b
i
i
z k C NEC C NEC
z
z
τ τ+ − > >
= 

 (21) 
where Cb is the internal concentration of the toxicant in the cell, kt is the killing rate and NEC is the no 
effect concentration term (Lopes et al., 2005; Billoir et al., 2007). This equation will modify the terms 
Pi and Gi ,i.e., Eqs. (3)-(4), in the stage-based Leslie matrix Eq. (2). In principle, it is possible to 
introduce a different expression for each cell stage. However, for simplicity reasons and due to the fact 
that the data to validate the model does not allow to distinguish this aspect, we have considered global 
kt and NEC values. Furthermore, even though in this work we have only considered mortality effects, 
other effects could also be treated using a similar approach by introducing different expressions in the 
toxicity effects model. This was already proposed and developed by Kooijman and Bedaux (1996) 
who considered effects in reproduction for Daphnia magna and other organisms. In the case of cell-
based assays a fecundity rate expression that modifies F as a function of chemical concentration could 
also be developed, i.e.  


 >>−−
=
F
NECCNECCkF
F FFbF 0
 and  if   )( ττ
 (22) 
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2.4. ESTIMATION OF MODEL’S PARAMETERS AND CORRELATIONS 
2.4.1. Experimental set-up characteristics 
The experimental procedure for the 3T3 BALB/c Neutral Red Uptake (NRU) cytotoxicity assay was 
developed for the NICEATM/ECVAM validations study requirements (ICCVAM, 2006a, b), whereas 
issues concerning the automation and the implementation of the assay using the Pilot Test Platform 
(PTP) of the IHCP automated test facility may be found in Bouhifd et al. (2005) and Bouhifd and 
Whelan (2006). 
The results of the testing for the validation study have been reported in ICCVAM (2006a) whereas the 
results obtained by testing 28 chemicals at the High Throughput Screening (HTS) platform are 
described in Norlén et al. (2007). 
The configuration of the 96-well test plate is shown in Fig.2. The dimensions of each well are: 
- Top internal radius: 3.425.10-3 m. 
- Bottom internal diameter: 3.175.10-3 m. 
- Depth: 10.76 .10-3 m. 
- Bottom area 3.16 .10-5 m2 
 
Figure 2. Configuration of the 96-well test plate. Blue: cells with dosing solutions of test chemical, six 
replicates for each dose and eight concentrations, C1 is the highest and C8 is the lowest concentration; 
green:  Black: only medium, blank experiments; green: Vehicle Controls (VC), contain cells in 
medium and no test compound (the VCs are considered to have 100% viability). 
 
With these dimensions and assuming the experiments contained 100 µL, i.e. VM = 10-7 m3, we can 
obtain: 
- Total well volume (assuming a truncated cone): 
( ) 722 10683.3
3
1
−
⋅=+⋅+= hRRrrVW pi  m
3
. 
- Headspace volume (m3): VH = 2.683.10-7 m3. 
- Surface of the well in contact with the medium, bottommM SgrrS ++= )(pi , where rm is the radius of 
the occupied volume and g is the slant height. SM = 9.392.10-5 m2. 
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- Surface of the cell-based assay medium, 52 10312.3 −⋅=⋅= mS rA pi m
2
. 
Assuming a 5% (v/v) serum in the medium, then [S]0 = 2.34 10-2 mol protein m-3. 
2.4.2. Concentration-response curves 
In this work we have used dose-response curves obtained at the HTS laboratory using the 3T3 BALB/c 
Neutral Red Uptake (NRU) cytotoxicity assay for the twenty compounds described in Table 1. These 
compounds have been used in several international exercises, eg., the NICEATM/ECVAM validation 
study and were studied previously in the laboratory (Norlén et al., 2007). 
 
Table 1. List of selected compounds. 
Compound CAS number Compound CAS number 
Acetaminophen 103-90-2 Amiodarone hydrochloride 19774-82-4 
Verapamil hydrochloride 152-11-4 Caffeine 58-08-2 
Acetylsalicylic acid 50-78-2 Carbamazepine 298-46-4 
Maprotiline 10262-69-8 Colchicine  64-86-8 
Cycloheximide 66-81-9 Acrylamide 79-06-1 
Sodium lauryl sulfate 151-21-3 Diphenhydramine 58-73-1 
tert-Butyl hydroperoxide 75-91-2 Pentachlorophenol 87-86-5 
Valproic acid 99-66-1 Disopyramide 3737-09-5 
Rifampin 13292-46-1 Chloroquine diphosphate 50-63-5 
Thioridazine hydrochloride 130-61-0 Tetracycline hydrochloride 64-75-5 
 
The physico-chemical properties and parameters that depend on the compound needed to run the 
model are described in Table 2. MW, log Kow and H were obtained from EPI suite v4.0 (experimental 
values were preferred over predictions), the molecular volume at the boiling point -vb- was calculated 
using the group method from Schotte (1992) and the contribution to the atomic diffusion volumes, 
ΣυΒ , for use in estimating D by the method of Fuller et al. (1966) were obtained by applying the 
values from Table A1 in the appendix to the selected compounds. 
Figures 3 and 4 show the fitted concentration-response curves for the twenty selected chemicals, 
whereas in Table 3 the obtained IC50 values are compared with those provided by Clothier et al. 
(2008). Concentration response curves were fitted using the biphasic equations from Beckon et al. 
(2008): 
1 1
1 ( / )1 ( / ) up dndnup
y
xx
β βεε
  
=     ++   
 (23) 
with  βup>0 and  βdn<0. Following Beckon et al. (2008) the β-values represent the steepness, whereas 
ε–values represent the dose at the mid-point of the rising and of the falling respectively.  This approach 
was introduced by Beckon et al. (2008) to consider biphasic relationships in dose-response curves and 
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it can be extended to consider more than one positive and negative effect. 
Table 2. Physico-chemical properties/parameters used in the model.  
Compound MW (g mol-1) log Kow H (Pa m3 mol-1) Vb (cm3 mol-1) ΣυΒ  
Acetaminophen 151.17 0.46 6.51.10-8 159.98 146.27 
Verapamil hydrochloride 491.08 3.45 1.41.10-9 966.03 535.12 
Acetylsalicylic acid 180.16 1.19 1.32.10-4 178.06 166.06 
Maprotiline 277.41 4.52 8.08.10-3 347.31 300.43 
Cycloheximide 281.35 0.55 3.57.10-10 363.44 280.25 
Sodium lauryl sulfate 288.38 1.60 1.12.10-10 359.59 286.42 
tert-Butyl hydroperoxide 90.12 0.94 1.62 112.66 96.76 
Valproic acid 144.22 2.75 3.04.10-1 194.78 174.64 
Rifampin 822.96 4.24 2.75.10-37 850.96 811.86 
Thioridazine hydrochloride 407.04 4.93 9.56.10-14 375.85 384.04 
Amiodarone hydrochloride 645.32 7.57 1.82.10-7 523.10 447.45 
Caffeine 194.19 -0.07 3.63.10-6 206.06 133.74 
Carbamazepine 236.28 2.45 1.10.10-5 234.37 227.52 
Colchicine  399.45 1.30 1.82.10-12 395.84 390.47 
Acrylamide 71.08 -0.67 5.98.10-4 80.92 70.57 
Diphenhydramine 255.36 3.27 5.44.10-4 298.91 292.85 
Pentachlorophenol 266.34 5.12 1.27.10-2 192.27 183.73 
Disopyramide 339.48 2.58 2.62.10-11 420.11 380.38 
Chloroquine diphosphate 319.88 4.63 1.09.10-7 376.82 394.68 
Tetracycline hydrochloride 482.92 -3.70 1.27.10-26 457.57 406.42 
 
 
Figure 3. Concentration-response curves (experimental and fitted data) for the first set of selected 
chemicals. 
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Figure 4. Concentration-response curves (experimental and fitted data) for the second set of selected 
chemicals. 
 
Table 3. Calculated IC50 values compared with Clothier et al. (2008) and observed LD50 for the 
selected chemicals. 
Compound IC50 (M) IC50 (M) ± sd 
Clothier et al. (2008) 
Observed LD50 (mg kg-1)  
 
Acetaminophen 2.19.10-4 (3.32 ± 1.20) .10-4 2052±187 
Verapamil hydrochloride 7.89.10-5 (7.25 ± 1.59) .10-5 109 
Acetylsalicylic acid 4.66.10-3 (4.32 ± 2.38) .10-4 818±660 
Maprotiline 2.33.10-5 (1.97 ± 0.44) .10-5 700 
Cycloheximide 6.04.10-7 (1.04 ± 1.24) .10-6 1.6±0.6 
Sodium lauryl sulfate 1.73.10-4 (1.61 ± 0.28) .10-4 1254 
tert-Butyl hydroperoxide 4.20.10-5 (6.11 ± 8.34) .10-5 388 
Valproic acid 9.48.10-3 5.78.10-3 1471 
Rifampin 1.78.10-4 (1.01 ± 1.05) .10-4 1272 
Thioridazine hydrochloride 1.07.10-5 (6.51 ± 4.31) .10-5 1038 
Amiodarone hydrochloride 3.2.10-5 (2.63 ± 1.05) .10-5 3000 
Caffeine 1.66.10-3 (8.31 ± 2.55) .10-4 229±64 
Carbamazepine 4.06.10-4 (4.61 ± 1.86) .10-4 2251±514 
Colchicine  9.15.10-8 (1.21 ± 1.15) .10-7 11 
Acrylamide 1.11.10-3 - 121±66 
Diphenhydramine 1.83.10-4 - 380 
Pentachlorophenol 9.3.10-5 (1.91 ± 3.54) .10-4 45±31 
Disopyramide 1.39.10-4 (2.70 ± 2.52) .10-3 333 
Chloroquine diphosphate 2.08.10-5 (2.30 ± 0.57) .10-5 500 
Tetracycline hydrochloride 1.18.10-3 (8.31 ± 3.04) .10-4 6442 
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To account for degradation during the experiment, the estimated half-lives using the Level III fugacity 
multimedia model provided by EPI suite v4.0 (Mackay, 2001) were chosen and a degradation constant 
was calculated for water and air as described in the Appendix. The values are summarized in Table 4. 
In principle for the more biodegradable compounds in water, a 10% concentration decrease in 48 hours 
was obtained, whereas for the persistent compounds less than 1% concentration decrease will occur. In 
air, degradation is normally fast, but their amount depends on the volatility of the chemical. These 
values are only a crude approximation and do not take into account cell metabolism, but at least they 
give an indication on the chemical stability of the compound. Due to the absence of experimental 
concentration measurements during these experiments, the model optimization tried to improve this 
estimation in a second step as a function of the experimental concentration-response curves (see 
Results section). 
 
Table 3. Degradation constants based on EPI estimated half-lives in water and in air. 
Compound kdeg (s-1) degairk  (s-1) 
Acetaminophen 0.535.10-6 1.33.10-5 
Verapamil hydrochloride 0.045.10-6 9.00.10-5 
Acetylsalicylic acid 0.535.10-6 9.82.10-7 
Maprotiline 0.214.10-6 7.05.10-5 
Cycloheximide 0.214.10-6 4.91.10-5 
Sodium lauryl sulfate 0.535.10-6 1.11.10-5 
tert-Butyl hydroperoxide 0.535.10-6 2.25.10-6 
Valproic acid 0.535.10-6 6.13.10-6 
Rifampin 0.045.10-6 6.59.10-4 
Thioridazine hydrochloride 0.134.10-6 1.93.10-4 
Amiodarone hydrochloride 0.045.10-6 1.24.10-4 
Caffeine 0.535.10-6 1.46.10-5 
Carbamazepine 0.214.10-6 2.37.10-4 
Colchicine  0.134.10-6 6.98.10-4 
Acrylamide 0.535.10-6 9.63.10-6 
Diphenhydramine 0.214.10-6 9.53.10-5 
Pentachlorophenol 0.045.10-6 4.13.10-7 
Disopyramide 0.045.10-6 9.39.10-5 
Chloroquine phosphate 0.134.10-6 1.13.10-4 
Tetracycline hydrochloride 0.134.10-6 1.54.10-4 
 
2.4.3. Measuring cell population  
The Neutral Red Uptake (NRU) cytotoxicity assay is a validated method to measure the 3T3 cell 
population in wells relative to the negative control well. However, as it is a destructive assay it does 
not allow time-lapse monitoring of cell population growth over time. Therefore, we applied a non-
invasive bright field imaging microscopy that made it possible to observe cell population, count their 
number, and track their divisions, detachments and apoptosis. The mouse BALB/c 3T3 cells were 
cultured in Dulbeco’s Modified Eagle’s Medium (DMEM) (Sigma, D 5796) supplemented with 10% 
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NCS. The cells were passaged at least three times in 75 cm2 culture flasks (Corning 430641) before 
being seeded in 16 chamber slides (Invitrogen C-37000) at a density of approximately 2000 cells per 
well. Immediately after seeding the cell populations started to be monitored by the bright field imaging 
microscopy on an inverted motorised microscope Olympus IX81. The cell populations were monitored 
over 4 days recording one picture per well every 10 minutes. This process was fully automated and no 
intervention of an operator was needed. During microscopy analysis, optimal cell growth conditions 
were maintained by using a stage humidified incubator that kept the temperature constant at 37°C and 
the partial CO2 pressure at 5%. After two days of incubation the culture medium was washed out and 
the tested chemicals dissolved in the culture medium (Verapamil: 1.22.10-4M, Acetaminophen: 3.31.10-
4M and 6.62.10-4M) were added to the wells. In two wells, which were used as negative control, the 
culture medium was changed for fresh one. At the beginning of the experiment the typical number of 
cells in the field of view of the microscope was in the range of 120-160. After 4 days, the number of 
cells in the non treated negative control wells was almost doubled, while in the treated wells it was 
progressively decaying over time. During picture analysis, only the cells that were well attached to the 
surface were taken into account. Results of the five populations are presented in fig. 5. 
 
Figure 5. Curves for the five population experiments: 1) and 2) controls, 3) Verapamil 1.22.10-4M, 4) 
Acetaminophen  3.31.10-4M and 5) Acetaminophen 6.62.10-4M added after 38.7 hours. 
 
2.4.4. Estimation of the chemical partitioning inside the cell 
A general approach to describe the distribution of the organic compound is by means of the partition 
coefficients ciK , defined as the relationships between the concentration in a particular component - for 
the cell proteins and lipids- and in the aqueous component. In this case we need to calculate cPK  and 
 14 
c
LK . Several of these correlations have been found in literature and all of them assume that the 
compound has a linear sorption isotherm which is normally a good approximation at low 
concentrations, i.e. there is no saturation. 
- Protein partitioning ( cPK ): 
The protein partitioning coefficient can be expressed as: 
[ ]Pc c
P
aq
C
PK
C
=  (24) 
where [P]c is the concentration of proteins in the cell and the partition coefficient cPK  is expressed in 
m
3.
mol-1. Therefore Kp in Eq. (16) is equal to: [ ]cP P cK K P= ⋅ . For 3T3 we will assume a constant 
value, [P]c = 11.096 mol protein m-3 (Meisler, 1973). 
In a compilation of blood protein (albumin) data DeBruyn and Gobas (2007) for different tissues found 
that the sorptive capacity of protein in solid animal tissues was higher than Kow for low log Kow 
chemicals (-1.3≤ log Kow ≤1.09) with a value around 1.31(±0.62) (ml g-1 albumin). For more 
lipophobic chemicals (1.09 < log Kow ≤ 4.6) the logarithm of the partition constant increased with log 
Kow following: 0.57 log Kow +0.69, whereas at higher Kow approached the lipid equivalence value of 
0.05, i.e. log Kow-1.3. Therefore, it is possible to write: 





>−
≤≥+⋅
<
=
6.4 log if   3.1log
6.4log1.09 if   69.0log57.0
09.1 log if   31.1
owow
owow
ow
KK
KK
K
valp
 (25) 
and then, 
( 1.178)10c valpPK
−
=  (26) 
where 1.178 is a factor to convert ml g-1 albumin to m3 mol-1 albumin. A MW = 66400 g mol-1 has 
been used for albumin. 
- Lipid partitioning ( cLK ): 
The partition coefficient of a chemical with cells lipids, cLK , could be written as: 
[ ]
c
L
c c
L
aq
C
LK
C
=  (27) 
where [L]c is the concentration of lipids in the cell (kg m-3). Therefore KL in Eq. (16) is equal to: 
[ ]cL L cK K L= ⋅ . For 3T3 cells, [L]c= 170.4 kg m-3 (Meisler, 1973). 
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Jonker and van der Heijden (2007) found for PAHs a linear correlation between the lipid-water 
partition coefficient and the octanol-water partition coefficient as: 
log 1.25( 0.06) log 3.70( 0.37)cL owK K= ± − ±  (28) 
This correlation was used by Kramer (2010) to calculate the partitioning of PAHs in medium lipids. 
Similar correlations have been found by other authors for different families of substances, but in this 
work, we assume that this correlation holds for all the compounds. 
 
Table 4. Estimated protein and lipid partition constants. 
Compound c
PK  (m3 mol-1) cLK (m3 kg-1 lipid) 
Acetaminophen 1.36 7.50.10-4 
Verapamil hydrochloride 30.10 4.10 
Acetylsalicylic acid 1.55 6.10.10-3 
Maprotiline 122.57 89.13 
Cycloheximide 1.36 9.72.10-4 
Sodium lauryl sulfate 2.65 2.0.10-2 
tert-Butyl hydroperoxide 1.36 3.0.10-3 
Valproic acid 12.01 0.55 
Rifampin 84.88 39.81 
Thioridazine hydrochloride 283.14 290.07 
Amiodarone hydrochloride 1.236.105 5.788.105 
Caffeine 1.36 1.63.10-4 
Carbamazepine 8.10 0.23 
Colchicine  1.79 0.0084 
Acrylamide 1.36 2.90.10-5 
Diphenhydramine 23.76 2.44 
Pentachlorophenol 438.53 501.19 
Disopyramide 9.61 0.34 
Chloroquine phosphate 141.91 122.32 
Tetracycline hydrochloride 1.36 4.73.10-9 
2.4.5. Estimation of cell permeability 
Assuming passive diffusion as the only transport mechanism, it is possible to write (Del Vento and 
Dachs, 2002) that the uptake constant, kupt (l g-1 d-1), is given by: 
pupt Spk ⋅=  (29) 
where p (m d-1) is the cell permeability and Sp is the specific surface of cells (m2 Kg-1), Sp=V2/3/W.  
There are several correlations to predict p as a function of physico-chemical properties of the 
molecule. In this work, we have used the experimental data obtained using caco-2 cells by Yazdanian 
et al. (1998) to fit an expression proposed in USEPA (1992) as a function of the octanol-water partition 
coefficient (Kow) and the molecular weight (MW). The following correlation has been obtained: 
MWKp ow 0011.0log98.01711.1log −+−=  (30) 
where p is given in cm h-1; to convert it to m d-1 then: 
)0011.0log98.01711.1(1024.0 MWKowp −+−⋅=  (31) 
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On the other hand, combining Eq. (29) and the first term in Eq. (17) it is possible to obtain the 
relationship between cell permeability and uptake rate: 
daupt rW
Vk
3/2
=  (32) 
Combining Eq. (29) with Eq. (31) rda can be estimated as: 
prda 10=  (33) 
where 10 is a factor to convert m d-1 to l.cm-2 d-1. 
In a similar way the depuration constant, kdep (d-1) can be obtained as (Del Vento and Dachs, 2002): 
BCF
Sp
k pdep
⋅
=  (34) 
where BCF is the Bioconcentration Factor (l g-1) defined as the ratio of concentrations of the chemical 
in the cell and in water - freely dissolved - at equilibrium. In addition, considering Eqs. (29) and (34) it 
is possible to observe that the relationship between uptake and depuration constants depends only on 
the bioconcentration factor and by comparing Eq. (34) and the second rhs term in Eq. (17) we can 
observe that the uptake and depuration rates are equivalent, rda=rad. Furthermore in our case the 
bioconcentration factor can be defined as: 
aq L P
L P
aq L P
f f fBCF K K
ρ ρ ρ
 
= + +  
 
 (35) 
Table 5 summarises the estimated values for rda. These values have been used as initial parameters in 
the optimization procedure to fit experimental concentration-response curves, see Section 2.6. 
 
Table 5. Estimated exchange rates constants of uptake and depuration between the cell and the medium 
and bioconcentration factors for 3T3. 
Compound rda (l.cm-2 s-1) BCF (l g-1) 
Acetaminophen 3.61.10-6 0.071 
Verapamil hydrochloride 1.30.10-3 0.2623 
Acetylsalicylic acid 1.74.10-5 0.0082 
Maprotiline 2.49.10-2 3.0150 
Cycloheximide 3.18.10-6 0.0071 
Sodium lauryl sulfate 3.34.10-5 0.0142 
tert-Butyl hydroperoxide 1.24.10-5 0.0072 
Valproic acid 6.44.10-4 0.0755 
Rifampin 3.30.10-3 1.4989 
Thioridazine hydrochloride 4.53.10-2 9.2277 
Amiodarone hydrochloride 9.58 1.6184.104 
Caffeine 9.78.10-7 0.0071 
Carbamazepine 2.59.10-4 0.0473 
Colchicine  1.28.10-5 0.0095 
Acrylamide 3.45.10-7 0.0071 
Diphenhydramine 1.60.10-3 0.1858 
Pentachlorophenol 9.94.10-2 15.6879 
Disopyramide 2.68.10-4 0.0577 
Chloroquine phosphate 2.87.10-2 4.0050 
Tetracycline hydrochloride 1.30.10-10 0.0071 
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2.5. OPTIMIZATION PROCEDURE FOR FITTING CONCENTRATION-RESPONSE 
CURVES 
There are four/five parameters that have to be calculated from toxicity data sets and then used to 
perform predictions. These are: rda, and rad the exchange rates constants of uptake and depuration 
between the environment and the internal concentrations in 3T3, but they are both correlated; kt, the 
killing rate constant for the mortality increase as a function of the chemical,  the NEC, No-effect 
concentration for survival, which is the threshold concentration after which the toxic effects start, and, 
finally the decomposition (external to the cell)/metabolism(internal to the cell) rates, which were 
estimated as liquid and air half-lives times without metabolism. To obtain these parameters the 
integrated model, i.e. contaminant fate, cell population and toxicity effects, was run and the results 
compared with dose-response curves. Due to the absence of chemical concentration measurements 
during the experiments and to reduce the possibility of multiple minima, i.e. combination of 
parameters that would be able to simulate the same concentration-response curve (Zaldívar and 
Baraibar, 2011), the optimization was performed in two steps. In the first step disappearance rates from 
Table 3 and  rda, and rad from Table 5 and no-metabolism were used and only kt, and NEC were 
optimized. Constrained optimization (only positive values) was carried out to minimize the error 
between modelled and fitted concentration-response curves using the Optimization ToolboxTM from 
MATLAB®. Afterwards all parameters were let to change and simulated annealing and genetic 
algorithms were used to explore the parameters’ space followed by a constrained optimization when a 
plausible minimum was obtained. 
 
3. RESULTS AND DISCUSSION 
3.1. STAGE-BASED 3T3 CELL GROWTH MODEL 
Since we are interested in coupling this model with a cell cycle model (e.g., Gérard and Goldbeter, 
2009), the model was divided in four stages (phases) - G1, S, G2, M- corresponding to the cell cycle. 
Data in percentage on the duration in each stage for 3T3 was taken from Migita et al. (2010), d3T3 = 
[50.7, 19.2, 18.2, 11.9], whereas the total duration was taken as 19 h (Zaldívar et al., 2010). Mortalities 
were obtained from Kudryavtsev et al. (2004), zi= [0.005, 0.005, 0.04, 0.04] (h-1). F was considered as 
an optimization parameter. 
Figure 6 shows the comparison between experimental growth data and model results (sum of all cells 
in the four stages). As can be observed 3T3 show an exponential growth during the duration of the 
experiment. These parameters were kept during the subsequent simulations.  
Once we have a growth model of 3T3 cell lines and the model of the fate of the compound in the in 
vitro assay (Zaldívar et al., 2010), we can now try to simulate cell-based assays “in silico”. 
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Figure 6. Simulated (continuous line) and experimental data on 3T3 cell population growth. Estimated 
3T3 parameter: F=1.0261.  
 
3.2. TOXICITY ASSAYS 
 
3.2.1. Estimation of the killing rate and the no-effect concentration 
Using the estimated values of rda and the environmental degradation rates provided by EPI suite v4 (), 
we performed the fit of kt and NEC. The optimization error was calculated as: 
exp
exp. .
1
( )
on
sim
i
error Viability Viability
=
= −∑  (36) 
The obtained results are shown in Table 6, whereas in Figs. 7-26 the fitted concentration-response 
curves are shown, as well as the corresponding cell population dynamics and dissolved and internal 
concentrations. As it can be observed in Table 6, there are three compounds that have a high error after 
the optimization: Cycloheximide, Thioridazine hydrochloride and Colchicine, whereas for another two 
- Sodium lauryl sulfate and Amiodarone hydrochloride- the error is still high when compared with the 
rest of the compounds. For these five compounds we decided to perform an optimization including not 
only kt and NEC, but also the rest of the model parameters estimated with empirical correlations or 
kept to zero due to the absence of data, i.e. decomposition reaction, uptake, depuration and metabolism 
rates. In any case looking at the concentration-response curves, it seems that in some cases there is a 
saturation of viability on the higher values of concentration. This effect may have a simpler 
explanation, i.e. solubility limit has been reached and therefore the nominal concentration in the 
system is, at these values, independent of the amount introduced in the system. However, solubility 
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data in pure water for Cycloheximide: 7.464 10-2 M ( 2 °C) and for Colchicine 1.088 10-1M (25 °C) 
seem to contradict this explanation. 
 
Table 6. Estimated kt and NEC values and associated error for the selected chemicals. 
Compound kt (s-1) NEC (g gww-1)  error 
Acetaminophen 2.20 1.15.10-3 190 
Verapamil hydrochloride 18.55 7.44.10-3 0.3 
Acetylsalicylic acid 8.05.10-2 2.34.10-2 91 
Maprotiline 147.11 1.44.10-3 131 
Cycloheximide 295.35 0 1218 
Sodium lauryl sulfate 4.97 8.24.10-3 567 
tert-Butyl hydroperoxide 38.55 4.86.10-3 139 
Valproic acid 0.0567 6.52.10-2 34 
Rifampin 1.16 1.897.10-2 62 
Thioridazine hydrochloride 41.02 0.905.10-3 1210 
Amiodarone hydrochloride 5.173 2.943.10-3 315 
Caffeine 0.285 6.944.10-3 77 
Carbamazepine 0.959 9.696.10-3 146 
Colchicine  1.505.103 9.849.10-7 1505 
Acrylamide 1.89 1.263.10-3 106 
Diphenhydramine 2.39 4.258.10-3 80 
Pentachlorophenol 3.38 1.893.10-3 26 
Disopyramide 1.77 2.862.10-3 93 
Chloroquine diphosphate 24.66 3.1967.10-4 65 
Tetracycline hydrochloride 471.94 1.535.10-6 134 
 
 
Figure 7. Acetaminophen. a/ Experimental and simulated concentration-response. For an increasing 
concentration between 0 and 1.10-3 M (0.1.10-3 M steps): b/Relative number of living cells; c/ 
Dissolved concentration; d/ Internal concentration inside the cell. 
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Figure 8. Verapamil hydrochloride. a/ Experimental and simulated concentration-response. For an 
increasing concentration between 0 and 4.2.10-4 M (0.2.10-4 M steps): b/Relative number of living 
cells; c/ Dissolved concentration; d/ Internal concentration inside the cell. 
 
Figure 9. Acetylsalicylic acid. a/ Experimental and simulated concentration-response. For an 
increasing concentration between 0 and 3.10-2 M (0.2.10-2 M steps): b/Relative number of living cells; 
c/ Dissolved concentration; d/ Internal concentration inside the cell. 
 21 
 
Figure 10. Maprotiline. a/ Experimental and simulated concentration-response. For an increasing 
concentration between 0 and 5.10-3 M (0.2 M steps): b/Relative number of living cells; c/ Dissolved 
concentration; d/ Internal concentration inside the cell. 
 
Figure 11. Cycloheximide. a/ Experimental and simulated concentration-response. For an increasing 
concentration between 0 and 5.10-3 M (0.2 M steps): b/Relative number of living cells; c/ Dissolved 
concentration; d/ Internal concentration inside the cell. 
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Figure 12. Sodium lauryl sulfate. a/ Experimental and simulated concentration-response. For an 
increasing concentration between 0 and 5.10-3 M (0.2 M steps): b/Relative number of living cells; c/ 
Dissolved concentration; d/ Internal concentration inside the cell. 
 
Figure 13. tert-Butyl hydroperoxide. a/ Experimental and simulated concentration-response. For an 
increasing concentration between 0 and 3.10-4 M (0.2.10-4 M steps): b/Relative number of living cells; 
c/ Dissolved concentration; d/ Internal concentration inside the cell. 
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Figure 14. Valproic acid. a/ Experimental and simulated concentration-response. For an increasing 
concentration between 0 and 4.10-2 M (0.5.10-2 M steps): b/Relative number of living cells; c/ 
Dissolved concentration; d/ Internal concentration inside the cell. 
 
Figure 15. Rifampin. a/ Experimental and simulated concentration-response. For an increasing 
concentration between 0 and 4.10-4 M (0.5.10-4 M steps): b/Relative number of living cells; c/ 
Dissolved concentration; d/ Internal concentration inside the cell. 
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Figure 16. Thioridazine hydrochloride. a/ Experimental and simulated concentration-response. For an 
increasing concentration between 0 and 3.10-5 M (0.2.10-5 M steps): b/Relative number of living cells; 
c/ Dissolved concentration; d/ Internal concentration inside the cell. 
 
Figure 17. Amiodarone hydrochloride. a/ Experimental and simulated concentration-response. For an 
increasing concentration between 0 and 1.5.10-4 M (0.1.10-4 M steps): b/Relative number of living 
cells; c/ Dissolved concentration; d/ Internal concentration inside the cell. 
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Figure 18. Caffeine. a/ Experimental and simulated concentration-response. For an increasing 
concentration between 0 and 4.10-3 M (0.2.10-3 M steps): b/Relative number of living cells; c/ 
Dissolved concentration; d/ Internal concentration inside the cell. 
 
Figure 19. Carbamazepine. a/ Experimental and simulated concentration-response. For an increasing 
concentration between 0 and 9.10-4 M (0.5.10-4 M steps): b/Relative number of living cells; c/ 
Dissolved concentration; d/ Internal concentration inside the cell. 
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Figure 20. Colchicine. a/ Experimental and simulated concentration-response. For an increasing 
concentration between 0 and 2.6.10-6 M (0.2.10-6 M steps): b/Relative number of living cells; c/ 
Dissolved concentration; d/ Internal concentration inside the cell. 
 
Figure 21. Acrylamide. a/ Experimental and simulated concentration-response. For an increasing 
concentration between 0 and 15.10-3 M (1.10-3 M steps): b/Relative number of living cells; c/ Dissolved 
concentration; d/ Internal concentration inside the cell. 
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Figure 22. Diphenhydramine. a/ Experimental and simulated concentration-response. For an increasing 
concentration between 0 and 4.10-3 M (0.2.10-3 M steps): b/Relative number of living cells; c/ 
Dissolved concentration; d/ Internal concentration inside the cell. 
 
Figure 23. Pentachlorophenol. a/ Experimental and simulated concentration-response. For an 
increasing concentration between 0 and 7.5.10-4 M (0.5.10-4 M steps): b/Relative number of living 
cells; c/ Dissolved concentration; d/ Internal concentration inside the cell. 
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Figure 24. Disopyramide. a/ Experimental and simulated concentration-response. For an increasing 
concentration between 0 and 3.10-4 M (0.2.10-4 M steps): b/Relative number of living cells; c/ 
Dissolved concentration; d/ Internal concentration inside the cell. 
 
Figure 25. Chloroquine diphosphate. a/ Experimental and simulated concentration-response. For an 
increasing concentration between 0 and 3.6.10-4 M (0.2.10-4 M steps): b/Relative number of living 
cells; c/ Dissolved concentration; d/ Internal concentration inside the cell. 
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Figure 26. Tetracycline hydrochloride. a/ Experimental and simulated concentration-response curve. 
For an increasing concentration between 0 and 5.10-3 M (0.2.10-3 M steps): b/Relative number of living 
cells; c/ Dissolved concentration; d/ Internal concentration inside the cell. 
 
Due to the different physico-chemical properties of the twenty studied compounds, the dynamics of 
dissolved and internal concentrations changes appreciably from experiment to experiment. Concerning 
dissolved concentrations, it is possible to observe the differences in scale between the nominal 
concentration in the concentration-response curves and the dissolved concentrations time series. For 
hydrophilic compounds there is practically no difference, e.g., Caffeine in Fig. 18; whereas for 
hydrophobic compounds the differences increase reaching up to several orders of magnitude, see for 
example Fig. 17 for Amiodarone. In addition, it is also possible to observe for several compounds the 
role of decomposition reactions in the decrease of concentration over time. However, all these values 
should be checked with experimental data to confirm the right amount of these reactions since the 
medium is not comparable with environmental half lives we have used to implement the model. 
Concerning internal concentrations, hydrophobic compounds tend to reach saturation quite rapidly, 
whereas for hydrophilic compounds the time need is longer, being Tetracycline the extreme case 
where after 48 hours internal concentrations have not reach the saturation concentration yet. For two 
cases: Valproic and Acetylsalicylic acid, internal concentrations reach too high values to assume that 
no saturation occurs, therefore, at these values probably all correlations are not valid anymore. 
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Table 7 summarizes the main results obtained using a nominal concentration corresponding to the IC50 
value concerning dissolved and internal concentrations and their respective areas under the curve 
(AUC). 
 
Table 7. Calculated average values of Cdiss, Cb and the respective areas under the curve (AUC) for the 
selected chemicals at their IC50 nominal concentrations. 
Compound Cdiss (mol l-1) Cb (g gww-1)  AUCdiss (mol h l-1) AUCb(g h gww-1) 
Acetaminophen 2.03.10-4 7.1.10-3 9.7.10-3 0.384 
Verapamil hydrochloride 3.41.10-5 8.3.10-3 1.6.10-3 0.407 
Acetylsalicylic acid 4.3.10-3 1.9.10-1 2.1.10-1 9.245 
Maprotiline 1.65.10-6 1.5.10-3 7.93.10-5 0.072 
Cycloheximide 5.75.10-7 3.71.10-5 2.76.10-5 0.002 
Sodium lauryl sulfate 1.55.10-4 1.12.10-2 7.4.10-3 0.550 
tert-Butyl hydroperoxide 3.88.10-5 8.46.10-4 1.9.10-3 0.041 
Valproic acid 6.6.10-3 2.99.10-1 3.18.10-1 14.656 
Rifampin 2.27.10-5 3.2.10-2 1.1.10-3 1.567 
Thioridazine hydrochloride 2.76.10-7 1.0.10-3 1.32.10-5 0.051 
Amiodarone hydrochloride 5.84.10-10 6.0.10-3 2.80.10-8 0.293 
Caffeine 1.5.10-3 5.69.10-2 7.38.10-2 2.778 
Carbamazepine 3.23.10-4 2.17.10-2 1.55.10-2 1.066 
Colchicine  8.66.10-8 8.44.10-6 4.16.10-6 4.13.10-4 
Acrylamide 1.0.10-3 8.6.10-3 4.94.10-2 0.419 
Diphenhydramine 9.37.10-5 1.01.10-2 4.5.10-3 0.494 
Pentachlorophenol 1.45.10-6 6.0.10-3 6.95.10-5 0.296 
Disopyramide 1.07.10-4 1.07.10-2 5.2.10-3 0.527 
Chloroquine diphosphate 1.14.10-6 9.33.10-4 5.49.10-5 0.046 
Tetracycline hydrochloride 1.1.10-3 3.53.10-5 5.43.10-2 0.002 
 
3.2.2. Global estimation of model’s parameters 
To improve the parameter’s optimization for the compounds with the highest error, see Table 6, we 
decided, in addition to kt and NEC  for which correlations or no value has been provided, to free the 
rest of parameters. These are: rda and rad, kdeg and kmet. The results obtained are summarized in Table 8. 
As one would expect, as the number of parameters increases, the optimization errors tend to decrease. 
However, multiple minima where found which implies that the concentration-response curves alone 
are not enough to elucidate which is the best set of parameters that will fit the data, and concentration 
measurements become critical to validate the model. Therefore, even though we are able to fit the 
experimental data, the system is not completely observable with only the available experimental data 
and we cannot be certain that the simulated values of dissolved and internal concentrations are correct. 
Table 8. Estimated rda, kdeg, kmet, kt and NEC values and associated error for the selected chemicals. 
Compound rda(l cm-2 s-1) kdeg (s-1) kmet (s-1) kt (s-1) NEC (g gww-1)  error 
Cycloheximide 0.686.10-3 2.34.10-2 0 1.46.103 0 531 
Sodium lauryl sulfate 2.93.10-5 7.25.10-6 2.18.10-5 13.52 6.76.10-3 205 
Thioridazine hydrochloride 3.704.10-3 2.33.10-3 1.68.10-6 175.87 1.41.10-4 775 
Amiodarone hydrochloride 0.252 1.68.10-6 4.04.10-4 32.11 6.64.10-4 71 
Colchicine  5.552.10-5 1.035 0 2.49.107 0 974 
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Figure 27. Cycloheximide. a/ Experimental and simulated concentration-response curve. For an 
increasing concentration between 0 and 5.10-3 M (0.2.10-3 M steps): b/Relative number of living cells; 
c/ Dissolved concentration; d/ Internal concentration inside the cell (with the obtained parameters, the 
compound disappears rapidly from the well). 
 
Figure 28. Sodium lauryl sulfate. a/ Experimental and simulated concentration-response curve. For an 
increasing concentration between 0 and 4.10-4 M (0.5.10-4 M steps): b/Relative number of living cells; 
c/ Dissolved concentration; d/ Internal concentration inside the cell. 
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Figure 29. Thioridazine hydrochloride. a/ Experimental and simulated concentration-response curve. 
For an increasing concentration between 0 and 3.10-5 M (0.5.10-5 M steps): b/Relative number of living 
cells; c/ Dissolved concentration; d/ Internal concentration inside the cell.  
 
Figure 30. Amiodarone hydrochloride. a/ Experimental and simulated concentration-response curve. 
For an increasing concentration between 0 and 1.5.10-4 M (0.1.10-4 M steps): b/Relative number of 
living cells; c/ Dissolved concentration; d/ Internal concentration inside the cell. 
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Figure 31. Colchicine. a/ Experimental and simulated concentration-response curve. For an increasing 
concentration between 0 and 3.0.10-6 M (0.5.10-6 M steps): b/Relative number of living cells; c/ 
Dissolved concentration; d/ Internal concentration inside the cell. 
 
The results after the optimization of all these parameters point out to the fact that only viability data at 
48 h is not enough to properly validate the model and to have a precise idea of free and internal 
concentrations. It is necessary to anchor chemical concentrations with experimental data to be able to 
obtain reliable model’s parameters. Specifically, for cycloheximide and colchicine, better fits are 
obtained assuming fast degradation since the viability seems to reach a constant value at higher 
concentrations. 
3.2.3. Simulation of the cell population experiments 
Even though we tried to keep similar conditions to the 3T3 experiments carried out in the HTS 
laboratory, the field imaging microscopy experiment did not show the same growth rates as the initial 
growth experiment, see Fig. 6. For this reason, we decided to change only the F value to approximate 
the growth values in the control experiment, but kept the same parameters of the toxicity model. Figure 
32 shows the experimental versus simulated results. As it can be observed the model tends to predict a 
higher mortality and therefore a fast decrease in cell population. However the results are satisfactory in 
view of the viability variability between duplicates observed during the experiments, see Figs. 3-4. 
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Figure 32. Experimental versus simulated cell population dynamics. Only the fecundity parameter F 
was modified (F=0.65) to adjust the growth in the two control experiments: 1) and 2). 3) Addition of 
Verapamil 1.22.10-4M; 4) addition of Acetaminophen 3.31.10-4M and 5) addition of Acetaminophen 
6.62.10-4M. 
 
3.3. IN VITRO – IN VIVO EXTRAPOLATION 
On of the objectives for the development of a cell-based assay model was to develop a system able to 
calculate the concentrations that the cell experience, i.e., the free/unbound concentration, and also to 
estimate the internal concentrations inside the cell. In this sense it is possible to express the obtained 
IC50 as 50
freeIC  and the internal concentrations at IC50 as 50
intIC , and check if these values are better 
predictive tools for the in vivo LD50. In any case, in the future we plan to correlate these values with 
the corresponding values provided by a PBTK (Physiologically based toxicokinetic) model, correcting, 
or providing free and internal concentrations in vivo. This would allow comparing the “same” values. 
In this work, we are only able to provide a correction for the x-axis in the plot IC50-LD50. 
As it is already well-know, the comparison between IC50 and LD50 (see Fig. 33) provides a low 
correlation value, r2=0.505, for the twenty analysed compounds. The results obtained using the values 
of dissolved, internal and their respective areas under the curve (AUC) in Table 7 have been compared 
with the LD50 values (see Fig. 34); however, the r2 correlation values obtained does not improve the 
value obtained by the direct comparison between IC50 and LD50, i.e., 0.19 for Cdiss, 0.25 for Cb, 0.19 for 
AUCdiss, 0.25 for AUCb. There are two plausible explanations for these results, the first is that the 
concentrations predicted by the model are not correct -see the results and discussion in Section 3.2.-, 
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the second  is that the conversion in vivo is still missing and therefore we should correct also the y-axis 
in the plots.  
 
Figure 33. Comparison between IC50 and LD50 values for the twenty compounds analysed. 
 
 
Figure 34. Comparison between the measures in Table 7 and LD50 values for the twenty compounds 
analysed. 
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3.4. PREDICTION OF 24 h ACUTE TOXICITY IC50s 
An application of the model we have tested is the prediction of the concentration-viability response 
performing the experiments at 24h instead of 48 h. This may be used afterwards as an assessment of 
the model predictive capabilities. Table 9 shows the results obtained. As it can be observed comparing 
with Table 3, there is no a clear scaling factor since it changes from chemical to chemical.  
 
Table 9. Estimated 24 h IC50 values, using estimated parameters from the 48 h experiments, for the 
selected chemicals. 
Compound IC50 (M) 
24 h 
Acetaminophen 4.55.10-4 
Verapamil hydrochloride 8.45.10-5 
Acetylsalicylic acid 9.25.10-3 
Maprotiline 2.52.10-5 
Cycloheximide 8.47.10-7 
Sodium lauryl sulfate 2.10.10-4 
tert-Butyl hydroperoxide 6.01.10-5 
Valproic acid 1.78.10-2 
Rifampin 2.38.10-4 
Thioridazine hydrochloride 1.60.10-5 
Amiodarone hydrochloride 4.41.10-5 
Caffeine 3.94.10-3 
Carbamazepine 7.27.10-4 
Colchicine  2.24.10-7 
Acrylamide 3.03.10-3 
Diphenhydramine 2.90.10-4 
Pentachlorophenol 1.57.10-4 
Disopyramide 2.44.10-4 
Chloroquine diphosphate 3.35.10-5 
Tetracycline hydrochloride 3.68.10-3 
 
3.5. REPEATED DOSE SIMULATION 
One of the advantages of developing a model is that it can be used to simulate experiments that are not 
easy to perform. In this case, once the model parameters have been established, it is possible to try to 
establish a chronic toxicity value for 3T3 simulating the addition of a constant dose at periodic 
intervals. This type of assay cannot be carried out in vitro easily since medium has to be changed 
periodically to avoid starvation and cell cultures start to die after a certain period of time. This is 
similar to the approach followed by Zaldívar and Baraibar (2011) for Daphnia magna. 
As an example, Fig. 35 shows the simulated results for acrylamide in a 4 days experiment with 
periodical addition of the same initial dose of the compound each day. As it can be observed, in this 
case the IC50 is around 2.75.10-4 M compared with the value obtained previously in the 48 h 
experiment which was 1.11.10-3M.  
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Figure 35. Simulation of repeated dose in-vitro toxicity experiments. Example: Acrylamide with 
repeated initial dose each 24 h. 
 
4. CONCLUSIONS 
A cell growth and toxicity model based on DEB (Dynamic Energy Budget) theory has been developed 
and implemented to simulate the HTS (High Throughput Screening) laboratory toxicity experiments. 
The model allows estimating dissolved concentration in the medium as well as internal concentration 
in the cells. 
As the only data available correspond to concentration-response experiments, the validation of the 
predicted dissolved and internal concentrations has not been possible. The fact that similar fittings can 
be obtained with different set of parameters can be seen in the second optimization procedure where 
more parameters were let free. Further research will go in this direction since these values are essential 
for performing in vitro- in vivo extrapolation. In addition, in parallel we are developing the PBTK 
models to be able to extract from LD50 values the corresponding dissolved and internal concentrations. 
Concerning cell population dynamics under increasing concentrations of chemicals, the results 
obtained correspond qualitatively to the experiments performed using impedance measurements in the 
Toxcast project (Judson et al., 2011) for the A549 human lung cancer cell line. The next step in the 
validation of the model will consists on replacing the 3T3 cell growth model by the corresponding  
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A549 human lung cancer cell line model and then compare for the tested compounds the relative 
growth curves with the impedance measurements. 
Finally a proper sensitivity analysis will be carried out to study the influence of the different 
parameters on the system dynamics and to assess which factors affect the observed viability variability 
in the values obtained using replicates in the HTS laboratory experiments. Also the influence of errors 
in the initial conditions will be assessed. In addition, the differences between the time step of the stage-
based model, one hour, probably should be reduced to accommodate fast transient dynamics in the 
mass balance ordinary differential equations from the medium and the cells. 
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 APPENDIX A.  FATE AND TRANSPORT: MASS BALANCE MODEL
This appendix contains the version of the previously developed fate and transport mass balance model 
(Zaldívar et al., 2010) modified to consider the cells as another independent compartment and not as a 
part of the medium as it was developed in the previous version.
The fate and transport model consists of a dynamic mass balance that includes a time
chemical transport and fate model for calculating the chemical concentration in the medium as well as 
in the headspace. The gas phase has been included to consider,
cross contamination between the 96 wells in the TC plates, since the TC are not hermetic even though 
the system was designed to minimize this aspect. To quantify this phenomenon, there are not enough 
experimental data at the moment. 
Figure A1. Overview of the process included in the fate and transport model
 
 
Assuming a well mixed medium and headspace and that the sorption processes are fast compared with 
the other processes, then the mass balance equations for both co
- Total concentration in the medium
deg
T
M s AW upt M diss
dCV A F R k V C
dt
= ⋅ − − ⋅ ⋅
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A similar equation can be written for the headspace:
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deg
airair
H s AW l l H air
dCV A F A F k V C
dt
= − ⋅ − ⋅ − ⋅ ⋅  (A2) 
where VH refers to the headspace volume (l); the first term represents the transfer of chemical across 
the air-water interface, the second term represents the losses from the headspace due to gas exchange, 
which we will consider zero in this first approach and the third term represent transformation in the 
headspace, i.e. degradation, decomposition, etc. 
To model the partitioning of an organic chemical in the medium (Kramer, 2010), we can consider that 
the compounds are either purely dissolved (Cdiss), bound to the serum/proteins (CS) or to the lipids (CL) 
in the culture medium, bound to the (plastic/glass) surface of the culture vessel (Cp) and inside the cells 
which we model as a different compartment. Therefore, the total concentration of an organic 
contaminant in the medium, CT, can be described by following equation: 
M
T diss S L p
M
SC C C C C
V
= + + +   (A3) 
where SM refers to the surface of the well in contact with the medium. The partition of the compound 
between the different phases can be expressed as a function of the total (nominal) concentration in the 
well as: 
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after defining the following partition coefficients: 
-Serum protein partition coefficient KS (m3.mol-1) : 
diss
S
S C
S
C
K ][=  (A8) 
where [S] is the concentration of proteins in the medium (mole protein.m-3). 
- Lipid partition coefficient, KL (kg lipid m-3) 
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L
L
diss
C
[ L ]K
C
=  (A9) 
where [L] is the concentration of lipids in the medium (kg lipid m-3) 
- The partitioning constant to plastic, Kp (m): 
diss
p
p C
C
K =  (A10) 
where Cp (mol m-2) is the concentration sorbed in plastic. 
In this approach, we have assumed that the partitioning is fast compared with the rest of the processes. 
A. 1. Partitioning of chemicals 
A general approach to describe the distribution of the organic compound is by means of the partition 
coefficients Ki, defined as the relationships between the concentration in a particular medium and in 
the water. In this case we need to calculate: 
- Serum protein partitioning: 
Kramer (2010) found the following correlation studying PAHs: 
)12.0(29.0log)03.0(37.0log ±−±= owS KK  (A11) 
where the partition coefficient KS is expressed in m3.mol-1. In a compilation of blood protein (albumin) 
data DeBruyn and Gobas (2007) for different tissues found that the sorptive capacity of protein in solid 
animal tissues was higher than Kow for low Kow chemicals (-1.3≤ log Kow ≤2) with a value around 
1.31(±0.62) (ml g-1 albumin). For more lipophobic chemicals (2 < log Kow ≤ 5.1) the logarithm of the 
partition constant increased with log Kow following: 0.57 log Kow +0.69, whereas at higher Kow 
approached the lipid equivalence value of 0.05, i.e. log Kow-1.3. In addition, they recommended, for 
modelling purposes, to estimate the sorptive capacity of animal protein as 5% that of lipid. 
- Partitioning to lipids: 
We have used the same correlation than for lipids inside the cell, i.e. Eq. (28). In this case the amount 
of lipids in the medium changes from an initial value of 80 10-3 kg lipid m-3 (Gulden et al., 2001) to a 
value that depends on the cell mortality since the cell content is supposed to go to the medium. 
- Partitioning to well plate plastic: 
Kramer (2010) found a linear correlation between Kp and Kow for the PAHs (Polycyclic aromatic 
hydrocarbons) family.  
)80.0(94.6log)15.0(97.0log ±−±= owp KK  (A12) 
As an example, if we consider a well with half of the liquid and a hydrophobic compound such as 
Benzo[a]pyrene (log Kow = 6.13 and log Kp = -0.99), 98% of Benzo[a]pyrene binds to plastic. 
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A. 2. Air-Water Exchange 
Organic pollutants will move in the headspace of the well and since the TC plates are not hermetically 
close they will diffuse to the other wells during the experiment. The final concentration will depend on 
the physico-chemical properties of the assessed compound as well as on the dosed concentrations. As a 
first approximation, we will concentrate on simulating the air-water exchange on a well assuming no 
transport outside takes place, but we will write the mass balance equation and, when experimental data 
will become available, we will be able to model the diffusion to other wells in the plate. In this case, 
the exchange between the headspace and the aqueous medium occurs through diffusive gas exchange 
between the headspace and medium boundary layer. 
- Diffusive exchange  
The diffusive air-water exchange flux FAW (mol m-2 s-1) at the interface (i) is represented as 
(Westerterp et al., 1984): 
air
AW AW diss
GL
CF k C
K
 
= − 
 
 (A13) 
where 
airC  and dissC  are the gas-phase and the dissolved (liquid) concentrations (mol m-3), 
respectively. KGL is the dimensionless gas-liquid distribution coefficient, iLiGGL CCK = , and is 
calculated from the Henry’s law constant using: 
TR
HKGL
⋅
=   (A14) 
where R is the universal gas constant 8.314 10-3 kJ (mol.K)-1 and T is the temperature (K). The 
temperature dependence of Henry’s law constant can be expressed as: 






−
⋅
∆
+=
TR
H
HH vap 1
298
1
303.2
loglog 298  (A15) 
where H298 is the Henry’s law constant at 25 ºC (Pa.m3 mol-1), ∆Hvap is the enthalpy of volatilization 
from water (kJ mol-1), which have to be defined for each chemical compound.  
The mass transfer coefficient kAW ( m s-1)is given by following equation: 
1
11
−






+
⋅
=
LGLG
AW kKk
k  (A16) 
where and kG and kL are the mass transfer coefficients (m s-1) in the air and the water films, 
respectively.  
The liquid phase mass transfer coefficient, kL, is calculated from the mass transfer coefficient of CO2 
in the water side, 
2COL
k (Kanwisher, 1963) which when there is no wind has a constant value: 
2101.4
2
−
⋅=COLk  (m s-1), by applying a correction factor: 
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where Sc is the Schmidt number of the pollutant and 600 accounts for the Schmidt number of CO2 at 
298 K. The Schmidt number is defined as: 
ρ
µ
⋅
=
LD
Sc  (A18) 
where ρ and µ are the density and viscosity of the fluid respectively while DL is the coefficient of 
molecular diffusion of the dissolved compound. The temperature dependence of the diffusion 
coefficient in water is calculated with following correlation by Wilke and Chang (1955): 
T
V
MWD
b
L ⋅
⋅
⋅
=
−
6.0
5.012 )(104.7
µ
α
 (A19) 
where T is the temperature of the solvent (K) and µ is its viscosity (cP), Vb (cm3 mol-1) is the molar 
volume of the organic compound at its normal boiling point, MW is the molecular weight (g mol-1) of 
solvent and α is the association factor of the solvent, α = 2.6 for organic solutes diffusing into water 
(Perry and Chilton, 1984) and DL is given in m2 s-1. 
The gas phase mass transfer coefficient, kG, is calculated using the mass transfer coefficient for water, 
which for the case of no wind has a constant value: 30, 1032
−
⋅=HGk (m.s-1), and then 
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where DG and DG,H2O refers to the diffusion coefficients in the gas phase (air) of the chemical and 
water, respectively (Schwarzenbach et al., 2003). 
An empirical correlation that has been extensively used to estimate the diffusion coefficients in air, DG 
in m2 s-1, as a function of temperature is the one presented in Fuller et al. (1966): 
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 (A21) 
where T is the temperature (K), P is the pressure (atm), MW are the molecular weights (g mol-1) of air 
(28.8) and the organic compound, and υ are the atomic diffusion values, ΣυAir=20.1, that can be 
determined form the values in Table 1.  
 
Table 1. Atomic diffusion volumes for use in estimating D by the method of Fuller, Schettler and 
Giddings (1966). 
C 16.5 Cl 19.5 
H 1.98 S 17.0 
O 5.48 Aromatic ring -20.2 
N 5.69 Heterocyclic ring -20.2 
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For the specific case of water in air, which is used after to calculate the mass transfer coefficient in the 
gas phase, we have adjusted the experimental values modifying the atomic diffusion values, i.e. 
Συwater=10.8., then the diffusion coefficient of water in air is calculated as: 
75.19
0, 102365.12 TD HG
−
⋅=
 (A22) 
A.3. Degradation, Decomposition, Metabolism 
In absence of detailed experimental data, degradation, decomposition or metabolism fluxes (mol s-1) 
are represented as a first order reaction model. Therefore for degradation and decomposition in the 
medium we will have: 
deg deg
M
M dissF k V C= ⋅ ⋅  (A23)  
where Cdiss is the concentration of the contaminant in dissolved form and kdegr may be the degradation 
rate resulting from hydrolysis, photodegradation, etc. A similar equartion can be written for the 
headspace: 
 deg deg
H air
H airF k V C= ⋅ ⋅  (A24) 
Normally, when no detailed data is available, the degradation rate kdeg is calculated from half life times 
deg
1/2
ln 2k
t
=   (A25) 
In this work, we have assessed the effects of considering the use of the half life values provided from 
the multimedia model installed in EPI Suite v4.0 (see Table 3). 
For metabolism, we can assume the same principle and write: 
met met bF k C= ⋅  (A26) 
In this case we have assumed that no metabolism occurs, kmet=0, since no data was available for 3T3 
cells. 
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APPENDIX B.  NOTATION 
 
A Leslie matrix (describes the transformation of a population from time t, in hours, to time t+1) 
Al headspace losses surface area (m2) 
As medium-headspace exchange surface area (m2)  
C Concentrations (mol l-1) 
Cb Contaminant concentration in the cell (g gww-1) 
di duration within i-th stage (h) 
D diffusion coefficient (m2 s-1) 
fx mass fraction of compartment x (dimensionless) 
F Fecundity rate per unit time (h) 
F molar flow (mol m-2 s-1) 
gi growth probability 
Gi Probability of surviving and growing into the next stage i+1 
H Henry law constant (Pa m3 mol-1) 
kt killing rate 
KL cells-lipids partitioning coefficient (m3 kg-1 lipid) 
KGL gas-liquid distribution coefficient, 
Kow octanol-water partition coefficient 
KP plastic-medium partitioning coefficient (m) 
KS partitioning coefficient between serum proteins and medium (m3 mol-1) 
kAW two film mass transfer coefficient (m s-1) 
kG air film mass transfer coefficient (m s-1) 
kL liquid film mass transfer coefficient (m s-1) 
k reaction rate constant (s-1) 
MW Molecular weight (g mol-1) 
n number of moles (mol) 
nt Vector containing  number of cells at each stage (G1,S,G2 and M) at time t 
NEC No-Effect Concentration 
P pressure (Pa) 
Pi Probability of surviving and staying in stage i 
p Cell permeability (m)  
pi Survival probability 
R  universal gas constant 
r cell radius (m) 
rda Uptake rate (l cm-2s-1) 
rad Depuration rate (l cm-2s-1) 
Sc Schmidt number, 
[S] concentration of proteins in medium (mol m-3)  
S surface (m2) 
SM plastic- medium exchange surface area (m2) 
t time (s) 
T temperature (K) 
V volume (l) 
W wet weight (g) 
zi instantaneous mortality rate 
 
Greek symbols 
αG von Bertalanffy’s growth rate 
γi Growing probability 
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ρ density (g l-1) 
µ viscosity (cP) 
 
Subscripts and superscripts 
 
aq aqueous 
AW air-water 
degr degradation 
diss dissolved 
H Headspace 
L lipids 
l loses 
M medium 
p plastic 
P proteins 
S serum 
T total 
w  well 
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compare them. Concerning the in vitro side, in the first part of this work, we had developed and 
implemented, based on HTS (High Throughput Screening) laboratory data, a compound fate model 
using the partitioning approach. The developed fate model was able to predict the role of serum in 
toxicity assays as well as provide estimation on the partitioning of a certain compound between the 
headspace, plastic wall and the medium: attached to serum, free dissolved and attached to the cells. 
However, the partitioning approach assumes that the equilibrium is fast in comparison with the 
duration of the experiments which could not be the case for the partitioning to the cells. For this 
reason, a DEB (Dynamic Energy Budget) stage-based toxicity model has been developed and 
experimentally verified in the second part of this work. In addition, the model allows using internal 
concentrations as the toxicity scale allowing a toxicodynamics’ independent raking of the toxic 
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